CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to INCY

Ruxolitinib phosphate cream

Phase 2
Incyte Corporation (INCY)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Psoriasis

Clinical Trial

NCT00820950

Last updated: 12/4/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

May 5, 2041(14y 11m)

Patents Listed

39

Exclusivity

I-896NPPPEDM-285ODE-238ODE-373PED

Application

NDA 215309
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.